Predictive Significance Of Preoperative Systemic Immune-Inflammation Index Determination In Postoperative Liver Metastasis Of Colorectal Cancer

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2019 Oct 2

PMID 31571929

Citations 22

Authors

Yao Lu

Dao Xin

Feng Wang

Affiliations

Soon will be listed here.

Abstract

Purpose: Systemic inflammation and immune dysfunction have been proved to be significantly associated with cancer progression and metastasis in colorectal cancer (CRC). The aim of this retrospective study was to investigate the association between preoperative systemic immune-inflammation index (SII) and postoperative liver metastasis in CRC.

Patients And Methods: This retrospective study evaluated 182 patients with CRC who underwent surgical resection. The inflammation-based prognostic factors, including SII, neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), lymphocyte to monocyte ratio (LMR) and prognostic nutritional index (PNI), were calculated based on preoperative laboratory data. The univariate and multivariate logistic regression analysis was performed to identify the risk factors correlated with postoperative liver metastasis in CRC. Receiver operating characteristic (ROC) curves and decision curve analysis (DCA) were respectively used to assess the predictive ability and clinical usefulness of SII for postoperative liver metastasis in CRC.

Results: The univariate and multivariable analysis confirmed SII was independently correlated with postoperative liver metastasis in CRC (<0.001), and the ROC and DCA analysis demonstrated SII was superior to other inflammation-based factors in terms of predictive ability.

Conclusion: SII is an independent predictive indicator of postoperative liver metastasis for patients with colorectal cancer.

Citing Articles

The Relationship Between Novel Inflammatory Markers and Serum 25-Hydroxyvitamin D Among US Adults.

Zhao H, Zhao Y, Fang Y, Zhou W, Zhang W, Peng J Immun Inflamm Dis. 2025; 13(1):e70115.

PMID: 39807747 PMC: 11729997. DOI: 10.1002/iid3.70115.

Forkhead box D subfamily genes in colorectal cancer: potential biomarkers and therapeutic targets.

Chen Y, Qiao H, Zhong R, Sun L, Shang B PeerJ. 2024; 12:e18406.

PMID: 39494294 PMC: 11529599. DOI: 10.7717/peerj.18406.

Correlation study: Bone density and circulating inflammatory markers in postmenopausal patients.

Jin X, Wang Y, Wang H, Wang L, Huan B, Liu C Immun Inflamm Dis. 2024; 12(8):e1365.

PMID: 39092766 PMC: 11295089. DOI: 10.1002/iid3.1365.

Prognostic value of a nomogram model for postoperative liver metastasis of colon cancer.

Cheng D, Xu K, Liu H, Liu Y World J Gastrointest Surg. 2024; 16(4):1055-1065.

PMID: 38690047 PMC: 11056678. DOI: 10.4240/wjgs.v16.i4.1055.

Prognostic significance of systemic immune-inflammation index in patients with nonfunction pancreatic neuroendocrine tumor undergoing surgical resection.

Chen G, Liu L, Tan C, Tan Q, Chen Y, An X Cancer Med. 2024; 13(7):e7114.

PMID: 38553949 PMC: 10980930. DOI: 10.1002/cam4.7114.

References

Templeton A, McNamara M, Seruga B, Vera-Badillo F, Aneja P, Ocana A . Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014; 106(6):dju124. DOI: 10.1093/jnci/dju124. View

Dai Z, Zheng R, Zou X, Zhang S, Zeng H, Li N . [Analysis and prediction of colorectal cancer incidence trend in China]. Zhonghua Yu Fang Yi Xue Za Zhi. 2012; 46(7):598-603. View

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Proctor M, Morrison D, Talwar D, Balmer S, OReilly D, Foulis A . An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer. 2011; 104(4):726-34. PMC: 3049591. DOI: 10.1038/sj.bjc.6606087. View

Stojkovic Lalosevic M, Pavlovic Markovic A, Stankovic S, Stojkovic M, Dimitrijevic I, Radoman Vujacic I . Combined Diagnostic Efficacy of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Mean Platelet Volume (MPV) as Biomarkers of Systemic Inflammation in the Diagnosis of Colorectal Cancer. Dis Markers. 2019; 2019:6036979. PMC: 6360046. DOI: 10.1155/2019/6036979. View

Mariani F, Sena P, Roncucci L . Inflammatory pathways in the early steps of colorectal cancer development. World J Gastroenterol. 2014; 20(29):9716-31. PMC: 4123361. DOI: 10.3748/wjg.v20.i29.9716. View

Rogler G . Chronic ulcerative colitis and colorectal cancer. Cancer Lett. 2013; 345(2):235-41. DOI: 10.1016/j.canlet.2013.07.032. View

McArdle C, Hole D . Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation. Br J Cancer. 2002; 86(3):331-5. PMC: 2375219. DOI: 10.1038/sj.bjc.6600120. View

Takagi S, Sato S, Oh-Hara T, Takami M, Koike S, Mishima Y . Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2. PLoS One. 2013; 8(8):e73609. PMC: 3749157. DOI: 10.1371/journal.pone.0073609. View

10.

Zhang H, Xia H, Zhang L, Zhang B, Yue D, Wang C . Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer. Am J Surg. 2015; 210(3):526-35. DOI: 10.1016/j.amjsurg.2015.03.022. View

11.

Wu Y, Li C, Zhao J, Yang L, Liu F, Zheng H . Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis. World J Surg Oncol. 2016; 14(1):289. PMC: 5112720. DOI: 10.1186/s12957-016-1044-9. View

12.

Heinemann V, Fischer von Weikersthal L, Decker T, Kiani A, Vehling-Kaiser U, Al-Batran S . FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. Lancet Oncol. 2014; 15(10):1065-75. DOI: 10.1016/S1470-2045(14)70330-4. View

13.

Buccafusca G, Proserpio I, Tralongo A, Giuliano S, Tralongo P . Early colorectal cancer: diagnosis, treatment and survivorship care. Crit Rev Oncol Hematol. 2019; 136:20-30. DOI: 10.1016/j.critrevonc.2019.01.023. View

14.

Itzkowitz S, Yio X . Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004; 287(1):G7-17. DOI: 10.1152/ajpgi.00079.2004. View

15.

Liang R, Chen N, Li M, Wang X, Mao Q, Liu Y . Significance of systemic immune-inflammation index in the differential diagnosis of high- and low-grade gliomas. Clin Neurol Neurosurg. 2017; 164:50-52. DOI: 10.1016/j.clineuro.2017.11.011. View

16.

Smith J, King P, Lane R, Thompson M . Evidence of the effect of 'specialization' on the management, surgical outcome and survival from colorectal cancer in Wessex. Br J Surg. 2003; 90(5):583-92. DOI: 10.1002/bjs.4085. View

17.

Burr N, Hull M, Subramanian V . Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?. World J Gastroenterol. 2016; 22(13):3679-86. PMC: 4814654. DOI: 10.3748/wjg.v22.i13.3679. View

18.

DInca R, Cardin R, Benazzato L, Angriman I, Martines D, Sturniolo G . Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia. Inflamm Bowel Dis. 2004; 10(1):23-7. DOI: 10.1097/00054725-200401000-00003. View

19.

Tong Y, Tan J, Zhou X, Song Y, Song Y . Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. J Transl Med. 2017; 15(1):221. PMC: 5664920. DOI: 10.1186/s12967-017-1326-1. View

20.

Kurt M, Onal I, Sayilir A, Beyazit Y, Oztas E, Kekilli M . The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology. 2012; 59(117):1580-2. DOI: 10.5754/hge10444. View